![Nicholas Keher](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicholas Keher
Directeur Financier/CFO chez
OXFORD NANOPORE TECHNOLOGIES PLC
Fortune : 154 403 $ au 31/05/2026
Profil
Nicholas Patrick Keher is currently Director at Idis Ltd. since 2019 and Director at Idis Group Holdings Ltd. since 2019.
Former roles include Chief Financial Officer at BenevolentAI SA from 2022 to 2023; Group Chief Financial Officer & Director at Clinigen Ltd. from 2019 to 2021; Director at Iovance Biotherapeutics UK SP Ltd. from 2019 to 2021; Director at Clinigen Holdings Ltd.; Managing Director at Royal Bank of Canada from 2015 to 2019; Analyst at RBC Europe Ltd. (Broker) from 2015 to 2016; and Research Analyst at Investec Bank Plc (Broker) from 2011 to 2015.
Education includes graduation from the University of Aston.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 12/06/2026 | 79 991 ( 0,01 % ) | 154 403 $ | 31/05/2026 |
Postes actifs de Nicholas Keher
| Sociétés | Poste | Début |
|---|---|---|
| OXFORD NANOPORE TECHNOLOGIES PLC | Directeur Financier/CFO | 22/01/2024 |
Idis Group Holdings Ltd.
 Idis Group Holdings Ltd. MiscellaneousMiscellaneous Operates as a holding company | Directeur/Membre du Conseil | 19/03/2019 |
Idis Ltd.
 Idis Ltd. Drugstore ChainsRetail Trade Supplies pharmaceuticals and allied services to the healthcare industry | Directeur/Membre du Conseil | 19/03/2019 |
Anciens postes connus de Nicholas Keher
| Sociétés | Poste | Fin |
|---|---|---|
| BENEVOLENTAI S.A. | Directeur Financier/CFO | 25/05/2023 |
| CLINIGEN GROUP PLC | Directeur Financier/CFO | 25/08/2021 |
Clinigen SP Ltd.
 Clinigen SP Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Directeur/Membre du Conseil | 24/08/2021 |
| ROYAL BANK OF CANADA | Corporate Officer/Principal | 01/03/2019 |
RBC Europe Ltd. (Broker)
 RBC Europe Ltd. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 06/03/2016 |
Formation de Nicholas Keher
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
87
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Royal Bank of Canada
 Royal Bank of Canada Major BanksFinance Operates as a national commercial bank | Finance |
Oxford Nanopore Technologies Plc
 Oxford Nanopore Technologies Plc Electronic Equipment/InstrumentsElectronic Technology Develops instruments for electronic detection and analysis of molecules | Electronic Technology |
Idis Ltd.
Idis Ltd. Drugstore ChainsRetail Trade Supplies pharmaceuticals and allied services to the healthcare industry | Retail Trade |
University of Aston
 University of Aston Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
RBC Europe Ltd. (Broker)
RBC Europe Ltd. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Idis Group Holdings Ltd.
Idis Group Holdings Ltd. MiscellaneousMiscellaneous Operates as a holding company | Miscellaneous |
Investec Bank Plc (Broker)
 Investec Bank Plc (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Clinigen Ltd.
 Clinigen Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a pharmaceutical services company that engages in clinical trails, regulatory affairs, distribution and commercialization of pharma companies | Commercial Services |
Clinigen SP Ltd.
Clinigen SP Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Health Technology |
Clinigen Holdings Ltd.
 Clinigen Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
BenevolentAI SA
 BenevolentAI SA Packaged SoftwareTechnology Services Develops AI drug discovery platform to accelerate biopharma drug discovery | Technology Services |
